Michael J. LaBarre

2009

In 2009, Michael J. LaBarre earned a total compensation of $361.6K as Vice President, Product Development at Halozyme Therapeutics, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$63,358
Option Awards$49,486
Salary$241,365
Other$7,386
Total$361,595

LaBarre received $241.4K in salary, accounting for 67% of the total pay in 2009.

LaBarre also received $63.4K in non-equity incentive plan, $49.5K in option awards and $7.4K in other compensation.

Rankings

In 2009, Michael J. LaBarre's compensation ranked 7,855th out of 9,885 executives tracked by ExecPay. In other words, LaBarre earned more than 20.5% of executives.

ClassificationRankingPercentile
All
7,855
out of 9,885
21st
Division
Manufacturing
2,935
out of 3,690
21st
Major group
Chemicals And Allied Products
667
out of 866
23rd
Industry group
Drugs
477
out of 638
25th
Industry
Biological Products, Except Diagnostic Substances
85
out of 133
36th
Source: SEC filing on March 24, 2011.

LaBarre's colleagues

We found eight more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2009.

2009

Jonathan Leff

Halozyme Therapeutics

Chief Medical Officer

2009

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2009

Jonathan Lim

Halozyme Therapeutics

Chief Executive Officer

2009

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2009

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2009

William Fallon

Halozyme Therapeutics

Vice President, Manufacturing & Operations

2009

David Ramsay

Halozyme Therapeutics

Vice President Corporate Development

2009

Robert Little

Halozyme Therapeutics

Vice President and Chief Commercial Officer

News

You may also like